John T. Treace, CEO, Founder and Board Member
Mr. Treace founded Treace Medical Concepts, Inc. in January, 2014. Mr. Treace has over 25 years of expertise in medical device Marketing, Sales, and General Management. Mr. Treace is the former Senior Vice President of US Sales and Global Marketing for Wright Medical, Inc. (WMGI). During a 12 year tenure with Wright, Mr. Treace served in a number of senior management roles including V.P. of Marketing and G.M. - Biologics and Extremities. Prior to Wright, Mr. Treace was Director of Marketing for Medtronic Xomed (MDT) and Advertising & Marketing Director for start-up company, TreBay Medical Corp. Mr. Treace also served on the Board of ENTrigue Surgical, which was acquired by Arthrocare Corporation in July, 2013.
Joe W. Ferguson, Chief Operating Officer
Mr. Ferguson has spent the last 20 years in medical device development spanning foot and ankle, extremities, trauma, large joint reconstruction, and spine. Most recently, Mr. Ferguson served as General Manager of the Florida Co-Innovation group of IMDS after having spent 4 years dedicated to foot and ankle specific R&D with Wright Medical, Inc. (WMGI). Mr. Ferguson has held positions with a variety of responsibilities including R&D, Quality, Operations, Intellectual Property and Regulatory for companies such as Smith & Nephew (SNN), Wright Medical, Inc., DePuy a Johnson & Johnson company (JNJ), Spinal Dynamics (acquired by Medtronic), Medtronic and IMDS. Mr. Ferguson also has 8 issued US patents and 23 patents pending.
Jaime A. Frias, Vice President, General Counsel, Secretary and Chief Compliance Officer
Mr. Frias has over 30 years of legal and compliance experience primarily in the medical device market. He began his collaboration with the Company in 2014 as legal counsel and corporate secretary through his firm, Frias Legal PA. Mr. Frias is the former Vice President, Chief Legal Counsel for the Surgical Technologies division of Medtronic, Inc. (MDT). During a 15-year tenure with Medtronic he was responsible for all legal and compliance matters for the MDT Surgical Technologies division as well as for the MDT Latin America division from 2000 to 2005. Prior to joining MDT, he served as in-house counsel for Xomed Surgical Products, Inc. from 1998 until the acquisition of Xomed by Medtronic (MDT) in 1999. From 1991 to 1998 Mr. Frias was in private practice in Jacksonville, Florida with the firms of Mahoney, Adams & Criser PA (becoming a shareholder in 1996) and McGuireWoods LLP. Prior to that, from 1988 to 1991, he was an associate with the New York offices of Baker & McKenzie, focusing primarily on securities, mergers and acquisitions and international transactions, and participated in the Baker & McKenzie International Clerkship Program in New York during the summer of 1986 and Madrid, Spain during the summer of 1987. He received his JD from The University of Michigan Law School in 1988 and holds a Bachelor of Music with high honors from the University of Florida.
Dipak Rajhansa, Chief Sales Officer
Mr. Rajhansa has over 25 years of progressive sales and marketing leadership experience; his past 15 years focused on commercializing disruptive technologies in the extremity orthopaedic market. From 2002 to mid-2017 he held the position of Senior Vice President of Sales and Marketing for Skeletal Dynamics, an innovative leader in the extremity market. Prior to this he held senior commercial positions with companies such as Hand Innovations (acquired by J&J Depuy in 2006), Orthosurgical Implants, Ortheon Medical, and U.S. Surgical Corporation (acquired by Tyco in 1998). Mr. Rajhansa holds a B.A. in Political Science from Washington University and an MBA from New York University.
Shana Zink, Vice President Clinical Affairs and Reimbursement
Ms. Zink has over 25 years of research experience in the pharmaceutical and medical device arena with the past 15 years focused on global Clinical Research in various therapeutic areas including cardiovascular, orthopedic surgery, bariatric, oncology and plastic surgery. From 2013-2018, Shana was Vice President of Clinical Affairs at AtriCure, Inc., an innovative leader in the treatment of atrial fibrillation. Prior to AtriCure, she held positions with a variety of responsibilities including Quality Assurance and Clinical Affairs at J&J, Proctor & Gamble and Searle Pharmaceuticals (a Monsanto Company). Ms. Zink holds a B.S. in Biological Sciences from Northern Illinois University and obtained a certificate in Project Management from Boston University Corporate Education Center.
Sean F. Scanlan PhD, Vice President, Marketing & Medical Education
Mr. Scanlan has over 14 years of orthopaedic research and product development experience. Prior to joining Treace Medical Concepts, Inc., Mr. Scanlan spent 3 years in Research & Development at Smith & Nephew’s Advanced Surgical Devices division focused on product development and early-stage technology assessment. Prior to this, he led a clinical research study at Stanford University with the Orthopaedic Surgery and Engineering departments, and served as a consultant for an early-stage orthopaedics start-up company, Moximed Inc. Mr. Scanlan holds a BS in Engineering Science (Biomechanics) from University of Florida, and an MS and PhD in Mechanical Engineering (Biomechanical Engineering division) from Stanford University.
Kirk A. Brennan, Vice President, Corporate Controller
Kirk has 18 years of experience as an accounting professional in both public accounting and private industry. Prior to joining Treace Medical Concepts, Inc. he spent twelve years in medical device as divisional controller within Biomet Inc.’s craniomaxillofacial business unit in Jacksonville, Florida . Prior to his experience in the medical device sector Kirk worked in public accounting for a regional CPA firm based in Jacksonville. He also worked in various finance roles at the Corporate headquarters of Armor Holdings, a manufacturing company located in Jacksonville. Kirk is a Certified Public Accountant and obtained his Bachelors of Business Administration (accounting) from the University of North Florida and a Masters of Business Administration degree from Jacksonville University. Mr. Brennan is a board member for the Jacksonville Speech and Hearing Center and a member of Jacksonville University’s alumni board of governors.
James T. Treace, Chairman of the Board
James T. Treace is the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company based in Jacksonville, Florida. Mr. Treace is the former President of Medtronic Xomed (MDT). Prior to its acquisition by Medtronic, Inc., in November 1999, Mr. Treace served as CEO, President and Chairman of the Board of Xomed Surgical Products, Inc. Additionally, he held CEO positions at TreBay Medical Corp., a private orthopaedic and microsurgical device company he co-founded; Concept, Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (CNMD); and Executive Vice President of Richards Medical, now known as Smith & Nephew (SNN). Former board positions include; Chairman of the Board of Kyphon, Inc. (now known as Medtronic Spine), Wright Medical, Inc. (WMGI), American Medical Systems, Inc. , now part of Endo Health Solutions, Inc. (ENDP) and Keystone Dental, Inc., a privately held dental implant company.
F. Barry Bays, Board Member
Mr. Bays is the former CEO & President and Chairman of the Board of Wright Medical, Inc. (WMGI) from 2000 to 2008. He was Chief Operating Officer of Xomed Surgical Products, Inc. prior to the acquisition by Medtronic, Inc. (MDT) and TreBay Medical Corp., a private orthopedic and microsurgical device company he co-founded. Additionally, he was the Chief Operating Officer of Concept, Inc., a leader in the arthroscopy device market - currently Conmed Linvatec (CNMD) - and VP of R&D of Richards Medical now known as Smith & Nephew (SNN).
Richard W. Mott, Board Member
Mr. Mott is currently Principal of Walkabout Consulting LLC, a management consulting and private equity firm, as well as Director/Owner of VFD Technologies. He currently consults for Warburg Pincus as an Executive in Residence, and Bio2 Technologies. In addition, he served as President, CEO and Director of Kyphon Inc., a NASDAQ-listed global medical device company through its acquisition by Medtronic, Inc. in late 2007. Prior to Kyphon, he was Chief Operating Officer at Wilson Greatbatch Technologies, Inc. and had executive operating roles within the Bristol-Myers Squibb Company. Current Board positions include Executive Chairman of MicroCHIPS, Inc., Chairman of Silk Road Medical, and Board member of Relievant Medsystems. Additionally, he is the previous recipient of the Ernst & Young Entrepreneur of the Year Award, the Frost & Sullivan Technology Leadership of the Year Award, and the Phoenix Lifetime Achievement Award. He holds a B.S. in Ceramic Engineering from Alfred University, and is a Graduate of Harvard University's Advanced Management Program.
John R. Treace, Board Member
John R. Treace is the President and Founder of JR Treace & Associates, a sales and marketing consulting firm in Jacksonville, Florida. Previously, Mr. Treace was Executive Vice President of North American Sales at Wright Medical, Inc (WMGI); Vice President of Sales at Medtronic Xomed (MDT); Vice President of Sales and Marketing of TreBay Medical Corp.; President of JR Treace & Associates, a medical device distribution company; and Vice President of Sales and Marketing of Richards Medical now known as Smith & Nephew (SNN). He is the author of Amazon’s top seller, Nuts & Bolts of Sales Management, How to Build a High Velocity Sales Organization, a monthly column contributor for Inc. Magazine, and a member of the National Speaker’s Association.
Thomas E. Timbie, Board Member
Thomas E. Timbie is the President of Timbie & Company, LLC, a financial and management consulting firm he founded in 2000. Mr. Timbie has over 30 years of financial experience primarily in the medical device market. During 2005, as the interim Chief Financial Officer of ev3 Inc., now part of Covidien (COV), Mr. Timbie helped lead ev3 through their initial public offering. He was also the CFO of Xomed Surgical Products, Inc. during their initial public offering in 1996 continuing in that role until the Company was acquired by Medtronic, Inc. (MDT) in 1999. Prior to Xomed, Mr. Timbie was the CFO of TreBay Medical Corp., a private orthopaedic and microsurgical device company and the Director of Accounting at Concept Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (CNMD). Mr. Timbie has also served as a board member and audit committee chairman of several public and private medical device companies including Wright Medical, Inc. (WMGI), ev3 Inc. acquired by Covidien (COV) in 2010, Acclarent, Inc., acquired by Johnson & Johnson (JNJ) in 2010 and American Medical Systems, Inc. acquired by Endo Pharmaceuticals (ENDP) in 2011. Mr. Timbie is also a former board member and audit committee chairman of two health care services companies; LaVie Care Centers and RegionalCare Hospital Partners.